The expert assessment of drug prescription for pharmacotherapy of thyroid diseases
DOI:
https://doi.org/10.24959/cphj.15.1357Keywords:
pharmacotherapy, thyroid disease, expert assessmentAbstract
It is known that the main factor that forms a demand for drugs for treatment of thyroid diseases is doctor. However this issue in the modern scientific literature is not properly highlighted. The aim of our study was to obtain reliable information about the range of drugs used for pharmacotherapy of thyroid diseases in Ternopil region hospitals. As experts were 35 endocrinologists from different medical institutions. The largest share were experts with practical experience of over 10 years (74.29%). The vast majority had qualification categories and the proportion of specialists who had higher and first category was 65.71%. Based on determination of coefficient competence into our formed team of experts were included questionnaires of 30 specialists. It was analyzed frequency of drugs prescription by experts for treatment and prevention of thyroid disease. We found that the largest percentage of use in practice of endocrinologists among levothyroxine sodium drugs is L-thyroxine 50 Berlin-Chemie. Among tiamazol advantage by the total number of prescriptions was equally Merkazolil Zdorovia 5 mg and Thyrozol 5 mg, but the last one is used more often. From iodine preparations (potassium iodide) 83.3% of experts prefer Yodomaryn® 200. It was determined significance of functional and other qualities of drugs. The most important feature of drugs that affect prescriptions, doctors have identified the effectiveness of drugs. Also it was identified which sources of information about drugs use in their work endocrinologists. Found that most doctors give preference to information about drugs from materials of scientific conferences and to medical representatives.References
Завгородня Т.П. Методи прогнозування [Електронний ресурс] / Т.П. Завгородня. – Режим доступу: http://lubbook.net/book_251.html. – 2014.
Колкутин В.В. Об отборе экспертов для анализа конкурентоспособности аппаратно-технических средств для проведения судебных экспертиз / В.В. Колкутин, П.В. Пинчук, О.А. Васнецова // Проблемы экспертизы в медицине. – 2005. - № 17-1 (том 5). – С. 5-8.
Левицька О.Р. Експертна оцінка лікарських засобів, які призначені для фармакотерапії інфаркту мозку / О.Р. Левицька, Б.П. Громовик, Н.П.Яворська, Г.М.Пришляк // Управління, економіка та забезпечення якості в фармації. – 2011. – № 6(20). – С. 52-58.
Максимкина Е.А. Конкурентоспособность фармацевтические организации в условиях рынка / Е.А. Максимкина, Е.Е. Лоскутова, В.В.Дорофеева - М: МЦФЭР, 1999. - 256 с.
Митник З. М. Стан ендокринологічної служби України в 2007 р. / З. М. Митник, Д. М. Панова, З. Г. Крушинська [та ін.] // Міжнародний ендокринологічний журнал. – 2008. – № 3(15). – С. 8-15.
Січінава Р.М. Сучасні аспекти динаміки ендокринної патології серед військовослужбовців ЗС України / Р.М. Січінава, Б.І. Паламар, О.М. Іванько, В.В. Якимець // Вісник проблем біології і медицини. – 2014. – Т. 3 (112), № 3. – С. 192-195.
Тронько Н. Д. Рак щитовидной железы у детей / Н. Д. Тронько. – Чернобыльинтеринформ, 1997. – 199 с.
Хвороби щитоподібної залози. Довідник цікавих фактів та корисних знань. – Режим доступу: http://dovidka.biz.ua/hvorobi-shhitopodibnoyi-zalozi-zalozi/
Downloads
Published
Issue
Section
License
Copyright (c) 2015 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
